73 active trials 43 recruiting 12 disease areas 15 changes in 30 days
| Phase 1 | 3 | |
| Phase 2 | 6 | |
| Phase 4 | 8 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT02639702 | Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia | Schizophrenia | Recruiting | 2026-08-25 |
| NCT04478838 | "Extended" (Alternate Day) Antipsychotic Dosing | Schizophrenia and Related Disorders | Recruiting | 2026-04-13 |
| NCT07109245 | Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect? | Brain Insulin Sensitivity | Recruiting | 2026-04-02 |
| NCT05744479 | Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability | Intellectual Disability | Recruiting | 2026-03-31 |
| NCT06346028 | Implementation of Transcranial Magnetic Stimulation for Smoking Cessation | Smoking | Recruiting | 2026-03-27 |
| NCT05515354 | Smoking Cessation and Menstrual Cycle Phase | Nicotine Dependence | Recruiting | 2026-03-19 |
| NCT06534047 | Transcranial Magnetic Stimulation for Nicotine Dependence: An… | Tobacco Use Disorder | Recruiting | 2025-12-11 |
| NCT06798324 | tDCS Plus Varenicline for Smoking Cessation | Nicotine Dependence | Recruiting | 2025-08-12 |
| Phase 2 | ||||
| NCT07211438 | Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant… | Treatment-Resistant Depression | Recruiting | 2026-08-21 |
| NCT06512220 | Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in… | Treatment Resistant Depression | Recruiting | 2026-07-30 |
| NCT06518720 | Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND) | Treatment Resistant Depression | Recruiting | 2026-07-30 |
| NCT06512389 | Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder | Alcohol Use Disorder | Active, Not Recruiting | 2026-09-16 |
| NCT06041152 | Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment | Amnestic Mild Cognitive Impairment | Active, Not Recruiting | 2026-02-25 |
| NCT07405606 | Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use… | Major Depressive Disorder (MDD) | Not Yet Recruiting | 2026-02-12 |
| Phase 1 | ||||
| NCT07033780 | Theta-Burst Stimulation to Treat Depression | Major Depressive Disorder (MDD) | Recruiting | 2025-06-24 |
| NCT06731621 | Psilocybin for Treatment-Resistant Depression in Autism | Treatment Resistant Depression | Active, Not Recruiting | 2026-08-06 |
| NCT03741478 | Intranasal Insulin and Olanzapine Study in Healthy Volunteers | Healthy Controls | Active, Not Recruiting | 2026-05-27 |
| Not applicable | ||||
| NCT05153369 | Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar… | Bipolar Disorder | Recruiting | 2026-10-01 |
| NCT05153382 | Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder | Bipolar Disorder | Recruiting | 2026-10-01 |
| NCT05627492 | Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster… | Bipolar Disorder | Recruiting | 2026-10-01 |
| NCT06928935 | Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for… | Clinical High Risk for Psychosis (CHR) | Recruiting | 2026-09-09 |
| NCT05142683 | Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled… | Major Depressive Disorder | Recruiting | 2026-08-20 |
| NCT06497920 | rTMS to Improve Motor Function in Autism | Autism Spectrum Disorder | Recruiting | 2026-06-15 |
| NCT07105449 | THC Titration of High-Potency Cannabis Concentrates | THC | Recruiting | 2026-06-11 |
| NCT07146633 | Efficacy of an EMDR App for PTSD and SUD | Posttraumatic Stress Disorder (PTSD) | Recruiting | 2026-05-22 |
Depression (20) · Schizophrenia (12) · Bipolar Disorder (6) · Alzheimer's Disease (4) · Dementia (3) · Diabetes (2) · ADHD (1) · Anxiety (1) · Obesity (1) · PTSD (1)